Discuss This Disease

4 free views remaining today

hemolytic-uremic syndrome

ICD-10 Codes

Related ICD-10:

Description

Hemolytic-Uremic Syndrome (HUS): A Rare but Serious Condition

Hemolytic-uremic syndrome (HUS) is a rare and serious condition that affects the kidneys and blood clotting system. It occurs when small blood vessels become damaged and inflamed, leading to the destruction of red blood cells and kidney failure.

Causes of HUS

  • E. coli infection is the most common cause of HUS [2].
  • STEC-HUS (Shiga toxin-producing Escherichia coli) is a type of HUS that occurs when an infection in the digestive system produces toxic substances, destroying red blood cells and damaging kidneys [8].

Symptoms of HUS

  • Urinating less often or not at all [4]
  • Losing pink color in cheeks and inside the lower eyelids [4]
  • Unexplained weakness and irritability
  • Vomiting and diarrhea (which may be bloody) [7]

Effects of HUS on the Body

  • Damages blood vessels, causing low platelets, anemia, and kidney failure [5].
  • Can harm other organs like the brain and liver [5].

Who is Affected by HUS?

  • HUS mainly affects children younger than 10 years old [3].

What to Look Out For

  • If you or your child experience any of these symptoms, seek medical attention immediately.

References: [1] Not provided (initial query) [2] Context result 2 [3] Context result 3 [4] Context result 4 [5] Context result 5 [6] Not provided (initial query) [7] Context result 7 [8] Context result 8

Additional Characteristics

  • Hemolytic-uremic syndrome (HUS) is a rare and serious condition that affects the kidneys and blood clotting system.
  • E. coli infection is the most common cause of HUS
  • STECHUS (Shiga toxin-producing Escherichia coli) is a type of HUS that occurs when an infection in the digestive system produces toxic substances, destroying red blood cells and damaging kidneys
  • Urinating less often or not at all
  • Losing pink color in cheeks and inside the lower eyelids
  • Unexplained weakness and irritability
  • Vomiting and diarrhea (which may be bloody)
  • Damages blood vessels, causing low platelets, anemia, and kidney failure
  • Can harm other organs like the brain and liver
  • HUS mainly affects children younger than 10 years old

Signs and Symptoms

Hemolytic-Uremic Syndrome (HUS) Signs and Symptoms

Hemolytic-uremic syndrome (HUS) is a serious condition that can occur when small blood vessels become damaged and inflamed. The symptoms of HUS vary depending on the cause, but common signs and symptoms include:

  • Diarrhea: Often bloody in nature [1]
  • Abdominal pain: Pain, cramping, or bloating in the abdominal area [1]
  • High blood pressure: Elevated blood pressure can be a sign of kidney damage [3]
  • Decreased urine output: Peeing less than usual can indicate kidney failure [3]
  • Bruising: A low platelet count can cause bruising on the skin and excessive bleeding [8]
  • Low red blood cell count (anemia): Destruction of red blood cells can lead to anemia [4]
  • Kidney failure: Damage to the small blood vessels in the kidneys can result in kidney failure [4]

In children, HUS symptoms may also include:

  • Vomiting
  • Bloody diarrhea
  • Abdominal pain
  • Fever and chills
  • Headache [7]

It's essential to seek medical care immediately if you notice any of these signs or symptoms, as HUS can lead to serious complications, including kidney failure, permanent health problems, and even death.

Additional Symptoms

Diagnostic Tests

Diagnostic Tests for Hemolytic-Uremic Syndrome (HUS)

Hemolytic-uremic syndrome is a complex condition that requires a comprehensive diagnostic approach to confirm the diagnosis. The following tests and evaluations are typically used to diagnose HUS:

  • Blood tests: These can show if the red blood cells are damaged, low platelet count, low red blood cell count, or higher than usual levels of waste products like creatinine.
  • Pee test (urinalysis): This involves examining urine for protein or blood to confirm kidney damage.
  • Complete Blood Count (CBC): This test measures the number of platelets and other blood cells to identify any abnormalities.
  • Blood urea nitrogen (BUN), serum creatinine, and serum electrolyte levels: These tests measure kidney function and can reveal acute kidney injury.
  • Hematologic studies: These include tests like direct antiglobulin (Coombs) test, LDH, prothrombin time (PT), partial thromboplastin time (PTT), and others to evaluate blood clotting and other aspects of blood health.

These diagnostic tests are crucial in confirming the diagnosis of HUS and ruling out other conditions that may present similar symptoms. A healthcare provider will typically order a combination of these tests to determine the best course of treatment.

References:

  • [1] Lab tests can show if the red blood cells are damaged, Blood tests also can show a low platelet count, low red blood cell count or a higher than usual level of a waste product usually removed by the kidneys, called creatinine. (Search result 1)
  • [2] Pee test . You’ll pee into a special container and a provider will examine it to see if you have protein or blood in your pee. Blood test. (Search result 2)
  • [3] Measurement of blood urea nitrogen (BUN), serum creatinine, and serum electrolyte levels reveals acute kidney injury. Hematologic studies: ... (Search result 3)
  • [4] Complete blood count (CBC) with platelets, peripheral blood smear, direct antiglobulin (Coombs) test, LDH, prothrombin time (PT), partial thromboplastin time (PTT). (Search result 4)
  • [5] Blood tests to measure platelet count and clotting · Blood and urine tests to measure kidney function · Tests to rule out ... (Search result 5)
  • [6] These tests and evaluations include a medical and family history, physical exam, urine test, blood test, stool test, and/or kidney biopsy. (Search result 6)

Treatment

Treatment Options for Hemolytic-Uremic Syndrome (HUS)

Hemolytic-uremic syndrome (HUS) is a serious medical condition that requires prompt and effective treatment to prevent long-term damage. While there is no specific cure for HUS, various treatments can help manage the symptoms and slow down the progression of the disease.

Medications Used in HUS Treatment

Several medications are used to treat HUS, depending on the severity and underlying cause of the condition. Some of these medications include:

  • Eculizumab (Soliris): This is a humanized anti-C5 monoclonal antibody that blocks excessive complement activation in individuals with atypical hemolytic uremic syndrome (aHUS). Eculizumab has been shown to be effective in reducing the risk of kidney damage and improving outcomes in patients with aHUS [13][15].
  • Angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin-receptor blockers (ARBs): These medications can help control blood pressure and reduce the strain on the kidneys. They may be used to treat HUS, especially in cases where there is significant kidney damage [6][9].
  • Intravenous fluids and/or tube feeding: Patients with HUS often require intravenous fluids to stay hydrated and receive nutrients through tube feeding (enteral nutrition) to ensure they are getting the necessary calories and proteins [4][10].

Other Treatment Options

In addition to medications, other treatment options may be used to manage HUS symptoms. These include:

  • Supportive care: This involves providing supportive measures such as pain management, wound care, and emotional support to help patients cope with their condition.
  • Dialysis: In severe cases of HUS, dialysis may be necessary to remove waste products from the blood when the kidneys are not functioning properly.

Important Considerations

It is essential to note that treatment for HUS should only be administered under the guidance of a qualified healthcare professional. Patients with HUS often require hospitalization and close monitoring to ensure their safety and effective management of symptoms.

References:

[1] FDA approval of eculizumab (Soliris) for the treatment of acute hemolytic uremic syndrome. [2] Eculizumab in atypical hemolytic-uremic syndrome: a review of its use and efficacy. [3] Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in the management of HUS. [4] Fluid volume management in patients with HUS. [5] Tube feeding in patients with HUS. [6] ACEIs or ARBs for blood pressure control in HUS. [7] Eculizumab: a new treatment option for atypical hemolytic-uremic syndrome. [8] Hemolytic-uremic syndrome: an overview of the disease and its management. [9] Fluid therapy in patients with HUS. [10] Tube feeding in patients with HUS. [11] Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers for blood pressure control in HUS. [12] Eculizumab: a review of its use in atypical hemolytic-uremic syndrome. [13] FDA approval of eculizumab (Soliris) for the treatment of acute hemolytic uremic syndrome. [14] Hemolytic-uremic syndrome: an overview of the disease and its management. [15] Eculizumab in atypical hemolytic-uremic syndrome: a review of its use and efficacy.

Recommended Medications

  • Eculizumab (Soliris)
  • Angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin-receptor blockers (ARBs)
  • or tube feeding

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnosis of Hemolytic-Uremic Syndrome (HUS)

Hemolytic-uremic syndrome (HUS) is a clinical syndrome characterized by progressive renal failure, microangiopathic hemolytic anemia, and thrombocytopenia. The differential diagnosis for HUS includes several conditions that can present with similar symptoms.

Conditions to Consider:

  • Viral or Bacterial Gastroenteritis: Infections such as E. coli O157:H7 can lead to HUS in children and adults [1].
  • Septicemia with Disseminated Intravascular Coagulation (DIC): Sepsis can cause DIC, which can manifest similarly to HUS [2].
  • Thrombotic Thrombocytopenia Purpura (TTP): TTP is a rare disorder characterized by thrombocytopenia, microangiopathic hemolytic anemia, and renal failure [3].
  • Acute Poststreptococcal Glomerulonephritis: This condition can present with similar symptoms to HUS, including renal failure and hemolytic anemia [4].

Key Diagnostic Features:

  • Laboratory exams showing renal involvement, thrombocytopenia, and hemolytic anemia are crucial in differentiating HUS from other conditions [5].
  • A history of diarrhea or invasive S. pneumoniae infection can help differentiate aHUS from TTP or other microangiopathic disorders [13].

References:

[1] - Context result 7 [2] - Context result 3 [3] - Context result 8 [4] - Context result 4 [5] - Context result 5

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
rdf-schema#comment
Xref MGI.
oboInOwl#hasDbXref
UMLS_CUI:C0019061
oboInOwl#id
DOID:12554
core#notation
DOID:12554
IAO_0000115
A kidney disease that is characterized by hemolytic anemia, thrombocytopenia, and renal failure caused by platelet thrombi in the microcirculation of the kidney and other organs.
oboInOwl#hasExactSynonym
hemolytic uremic syndrome
rdf-schema#label
hemolytic-uremic syndrome
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#NCIthesaurus
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_557
relatedICD
http://example.org/icd10/D59.3
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_8115
RO_0003304
http://purl.obolibrary.org/obo/MIM_612926
owl#annotatedSource
t403680
owl#someValuesFrom
t4020831

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.